StageZero Life Sciences (SZLSF) Stock Chart & Stock Price History → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free SZLSF Stock Alerts $0.01 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest StageZero Life Sciences Stock Price Performance5 Day Performance0.00%1 Month PerformanceN/A3 Month PerformanceN/A6 Month Performance-62.03%Year-To-Date Performance-59.18%1 Year PerformanceN/A Receive SZLSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> SZLSF Stock Chart for Tuesday, June, 18, 2024 SZLSF Chart by TradingView StageZero Life Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2024$0.01$0.01$0.01$0.008,716 shs$1.48 million06/12/2024$0.01$0.01-8.05%$0.01$0.008,716 shs$1.48 million06/05/2024$0.02$0.01-37.02%$0.01$0.011,000 shs$1.62 million06/04/2024$0.04$0.02-48.00%$0.02$0.022,000 shs$2.57 million05/21/2024$0.04$0.04$0.04$0.042,000 shs$4.94 million05/20/2024$0.01$0.04+212.50%$0.04$0.042,000 shs$4.94 million Get the Latest News and Ratings for SZLSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$0.01$0.01$0.01$0.012,000 shs$1.58 million05/09/2024$0.01$0.01$0.01$0.015,578 shs$1.58 million05/07/2024$0.01$0.01$0.01$0.01155 shs$1.58 million05/06/2024$0.01$0.01$0.01$0.01155 shs$1.58 million05/02/2024$0.01$0.01$0.01$0.012,000 shs$1.58 million05/01/2024$0.04$0.01-68.00%$0.01$0.012,000 shs$1.58 million04/30/2024$0.04$0.04$0.04$0.0434 shs$4.94 million04/29/2024$0.04$0.04$0.04$0.0415,640 shs$4.94 million04/25/2024$0.04$0.04$0.04$0.0315,640 shs$4.94 million04/24/2024$0.03$0.04+48.15%$0.04$0.0315,640 shs$4.94 million04/22/2024$0.03$0.03$0.03$0.03900 shs$3.34 million04/19/2024$0.04$0.03-30.77%$0.03$0.03900 shs$3.34 million04/18/2024$0.04$0.04$0.04$0.04950 shs$4.82 million04/17/2024$0.03$0.04+35.42%$0.04$0.04950 shs$4.82 million04/09/2024$0.03$0.04+38.89%$0.04$0.041.22 million shs$4.94 million04/08/2024$0.04$0.03-28.00%$0.03$0.03125,025 shs$3.56 million04/02/2024$0.04$0.04$0.04$0.04750 shs$4.94 million04/01/2024$0.04$0.04+14.12%$0.04$0.04750 shs$4.94 million03/29/2024$0.04$0.04-0.14%$0.04$0.0420,500 shs$4.33 million03/28/2024$0.04$0.04-12.25%$0.04$0.0420,500 shs$4.34 million03/27/2024$0.03$0.04+20.85%$0.04$0.0355,300 shs$4.94 million03/25/2024$0.03$0.03$0.03$0.031,100 shs$4.09 million03/22/2024$0.03$0.03+22.59%$0.03$0.031,150 shs$4.09 million Related Companies: MYMD Stock Price Chart VRAX Stock Price Chart GNWSF Stock Price Chart FPMI Stock Price Chart BGMD Stock Price Chart GWHP Stock Price Chart HMGN Stock Price Chart IPSEY Stock Price Chart NAVB Stock Price Chart RGDXQ Stock Price Chart Receive SZLSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SZLSF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
